StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) stock

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.00 (-2.08%)

Close on Nov 18, 2026Market cap $14.48MP/E –Yield –

Estrella Immunopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Estrella Immunopharma's market cap was $21.52M on Nov 11, 2026, against $77.25M a year earlier. Over the last 5 years it ranged from $2.27M to $88.60M, with a median of $33.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$21.52M-62.3%
2025Dec 31, 2025$57.11M+30.0%
2024Dec 31, 2024$43.93M+12.4%
2023Dec 29, 2023$39.07M+167.5%
2022Dec 30, 2022$14.61M+3.8%
2021Dec 31, 2021$14.07M–

More Estrella Immunopharma figures

See a number that looks wrong?